Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells
about
Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortalityThe role of alpha(v)beta(3) in prostate cancer progressionAssociation of serum osteoprotegerin with left ventricular mass in African American adults with hypertension.Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potentialOsteopontin: roles in implantation and placentation.Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype.Meta-analysis of genome-wide association studies identifies two loci associated with circulating osteoprotegerin levelsSpatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves.Plasma and drainage fluid levels of soluble receptor activator of nuclear factor-kB (sRANK), soluble receptor activator of nuclear factor-kB ligand (sRANKL) and osteoprotegerin (OPG) during proximal humerus fracture healing.Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis.Osteopontin: a leading candidate adhesion molecule for implantation in pigs and sheep.Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in micePlasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus.Phase II study of cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortiumSkeleton and glucose metabolism: a bone-pancreas loop.Apoptotic cues from the extracellular matrix: regulators of angiogenesis.(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis.Polymorphisms in three genes are associated with hemorrhagic stroke.Immunoregulation of bone remodellingOsteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2.Periodontitis and rheumatoid arthritis: a review.Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension.Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice.Osteoprotegerin as a marker of atherosclerosis in diabetic patients.The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.Osteoimmunology.Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.Biomarkers associated with pulse pressure in African-Americans and non-Hispanic whites.Expression and regulation of osteoprotegerin in adipose tissue.Vitamin D status in gastrointestinal and liver disease.Endothelial progenitor cells for cancer gene therapy.Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor geneBreast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact.Osteoprotegerin, vascular calcification and atherosclerosis.Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis.RANKL inhibition for the management of patients with benign metabolic bone disorders.Abdominal aortic aneurysm: a review of the genetic basis.The role of osteoprotegerin in cardiovascular disease.Cystic bone angiomatosis: a case report treated with aminobisphosphonates and review of the literature.Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin.
P2860
Q24623768-E5B48F3A-78C2-4E46-9607-0F19DFAB82D3Q24682923-397D90FC-E8CD-4B46-9492-F683DD6AAB15Q30477731-61740C84-90D8-4D33-AEDD-BA9205C945B0Q33615922-22A48025-79B2-4582-B489-C3C0470AC0B3Q34218572-15262E8C-204B-4163-A2F2-0BCB6BA6FB00Q34318454-7AA41B88-B1D5-4268-B889-B3047652C6ACQ34555532-112B3DBB-88F2-4851-BB60-28B02E3A3EF6Q34670503-11C12389-04B1-4753-99B4-FC67E17D5D05Q34828137-FCF893A9-6800-47A8-A222-50E92FBBA55EQ34950497-5BDEC69E-4F53-4319-B02B-FB08FB037733Q35066125-BD19C3AC-20A6-46B6-90E0-D53B7E2EBCE7Q35175707-E4C923F2-CC63-40D8-A163-6E5C5028A714Q35185705-A78F9EA4-658B-442D-96B6-E35B6DF43D56Q35218871-179C9620-5202-4438-BDFC-81B6CDB96335Q35250223-82896139-F49F-4ED4-B38D-5FFD0B87110BQ35603378-1535515D-7372-462D-A98E-3BEC66F5FB95Q35620276-1E1EF8EF-D2D7-4DBB-9806-FC23545D4A8CQ35868148-9FD1E182-6D50-40F0-BD34-58C4A215E18BQ36107934-2A309B00-3809-4A1E-922B-9624AA1BC3D3Q36248821-E5D7ABC1-7E39-4552-A379-792E0AF5E3FDQ36309246-897DDFD2-2B97-4A68-8592-6A1EE90E0724Q36340848-590DDBC6-0CD2-436C-AB9F-84D4948E42F3Q36530849-4E29DD78-3E88-4F9D-B7A1-43F4DF6D0FF1Q36582644-34AFE60E-1F9E-40A9-BCFA-862E292BCA36Q36686037-C3F949C6-85AD-4456-8C9A-8AF4787E130CQ36693328-470B29E7-1383-4AA0-8545-05350554FA75Q36860987-7C7C1B64-F1C1-4157-9774-DB17FA60F27EQ37000882-EF9E0479-091F-46C5-A6F5-7A1C7E3DAAF5Q37065591-A774C661-A6DE-43AB-8C4A-71D3254A70F3Q37095126-02DD82C0-34EB-43EA-B846-2D39555661A8Q37120174-1F3431AC-5F16-497D-9EA2-7545195F0D8EQ37149062-CD1EE074-7163-4D05-8AFD-6B69EF107D50Q37285702-3FB97DD0-F23A-4CBC-BB95-7BCA65DBA572Q37310825-811A88E1-6245-47E7-A3EC-7D0BE5858251Q37418199-3DEF02F5-F519-4DF0-8469-10FF88BAD523Q37532561-BCB75467-D120-4DD6-A349-B21FAC4D1771Q37766689-C816D69A-E3E1-4BAE-B50F-B4EA78BBAE75Q38056541-83BDDAA0-71B9-4540-B511-28D3757AB60DQ38120198-58B71B1C-D444-4FC2-945B-E2E2549C2EE1Q38338847-262240C0-6CD8-4E9C-95BA-A2E193E379BA
P2860
Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells
description
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
im Mai 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in Journal of Biological Chemistry
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2000
@uk
name
Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells
@en
Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells
@nl
type
label
Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells
@en
Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells
@nl
prefLabel
Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells
@en
Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells
@nl
P2093
P2860
P356
P1476
Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells
@en
P2093
Cecilia M. Giachelli
Katherine L. Suchland
Marta Scatena
Theodore J. Yun
Uriel M. Malyankar
P2860
P304
20959-20962
P356
10.1074/JBC.C000290200
P407
P577
2000-05-12T00:00:00Z